CCO Expert Recap

Non-Hodgkin’s Lymphoma

Source: American Society of Hematology 2007 Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Non-Hodgkin’s Lymphoma

CME Program Director:
Roy A. Beveridge, MD

Faculty:

Julie M. Vose, MD headshot
  • Julie M. Vose, MD

CME CREDIT INFORMATION

Release Date: 02/14/08

Expiration Date: 02/13/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Watch and listen as Julie M. Vose, MD, reviews the latest treatment data on non-Hodgkin’s lymphoma from the 2007 meeting in Atlanta.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Report recent data on the use of bortezomib in the treatment of mantle cell lymphoma
  • Summarize new treatment strategies for consolidation of follicular lymphoma
  • Describe the activity of rituximab in the treatment of lymphocyte-predominant Hodgkin’s disease
  • Discuss the role of prophylactic cranial irradiation in the treatment of aggressive non-Hodgkin’s lymphoma with bone marrow involvement

Slideset

Non-Hodgkin’s Lymphoma


Dowload slides on the latest non-Hodgkin’s lymphoma data from the 2007 hematology meeting.


Format: Microsoft PowerPoint (.ppt) | File size: 1,030 KB